Effects of blocking plasma lipid transfer protein activity in the rabbit

Plasma lipid transfer protein activity was completely blocked in rabbits for up to 48 h by infusion with goat antibody to rabbit lipid transfer protein. Lipid transfer protein activity in plasma of control animals, infused with antibody from a non-immune goat, decreased during the experiment but was never less than 50% of pre-infusion levels. During the period that lipid transfer protein activity was completely blocked, there were changes in high-density lipoprotein composition (expressed as % by weight) with a reduction in triacylglycerol from 8.4 +/- 2.4% to 1.0 +/- 0.2% (P less than 0.05) and an increase in esterified cholesterol from 10.7 +/- 1.7% to 14.5 +/- 0.3% (P less than 0.1). In conjunction with the observed changes in high-density lipoprotein composition, there was an increase in high-density lipoprotein particle size from a mean radius of 4.7 to 5.4 nm. The change in composition and particle size was not observed in high-density lipoproteins from control animals. There was a change in the distribution of plasma cholesterol in control animals, with a fall in the proportion of cholesterol in high-density lipoproteins (P less than 0.02) and consequently an increase in the proportion of cholesterol in low-density lipoproteins (P less than 0.02). However, the distribution of plasma cholesterol in animals in which lipid transfer protein activity was inhibited was maintained at original levels during the period of inhibition. Consequently, in these animals, there was a less atherogenic distribution of cholesterol during the period of lipid transfer protein inhibition when compared with control animals. The changes observed in lipoproteins, in the absence of lipid transfer protein activity, demonstrate that lipid transfer protein modifies lipoproteins in vivo and appears to contribute to a more atherogenic lipid profile.     

Cure of Lung Cancer from Incomplete Surgical Resection

Three patients with lung cancer have been cured by incomplete removal of the cancer, which has for 20 years been the policy of this unit when complete removal is not possible. In each patient residual cancer remained on the wall of the left atrial chamber of the heart at the end of an operation for pneumonectomy.Incomplete removal of cancer may, as a rare event, cure the patient. When residual cancer remained on any mediastinal structure other than the atrium cure has not been seen, though progress of the cancer seems to be retarted in some patients.     

Biofungicides as alternative to synthetic fungicide control of grey mould (Botrytis cinerea) – prospects and challenges

Botrytis cinerea is one of the most destructive pathogens of ve?getables and fruits both in the field and storage. There have been several research activities focused on developing biocontrol strategies for the pathogen due to its resistance to the commonly used synthetic fungicides. Additionally, concerns have been raised over residual effect of current synthetic fungicides used for its control. Most of these research activities have focused on Trichoderma spp., Ulocladium spp., Bacillus subtilis, plant extracts and their essential oils with some commercial products available on the market for the control of B. cinerea disease. This review summarises some of the current published information on the use of biocontrol agents and plant-based compounds for B. cinerea control. Some limitations and future prospects were also mentioned.     

The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study

Background

Adjuvant treatment with radioactive iodine (RAI) is often considered in the treatment of well-differentiated thyroid carcinoma (WDTC). We explored the recollections of thyroid cancer survivors on the diagnosis of WDTC, adjuvant radioactive iodine (RAI) treatment, and decision-making related to RAI treatment. Participants provided recommendations for healthcare providers on counseling future patients on adjuvant RAI treatment.

Methods

We conducted three focus group sessions, including WDTC survivors recruited from two Canadian academic hospitals. Participants had a prior history of WDTC that was completely resected at primary surgery and had been offered adjuvant RAI treatment. Open-ended questions were used to generate discussion in the groups. Saturation of major themes was achieved among the groups.

Findings

There were 16 participants in the study, twelve of whom were women (75%). All but one participant had received RAI treatment (94%). Participants reported that a thyroid cancer diagnosis was life-changing, resulting in feelings of fear and uncertainty. Some participants felt dismissed as not having a serious disease. Some participants reported receiving conflicting messages from healthcare providers on the appropriateness of adjuvant RAI treatment or insufficient information. If RAI-related side effects occurred, their presence was not legitimized by some healthcare providers.

Conclusions

The diagnosis and treatment of thyroid cancer significantly impacts the lives of survivors. Fear and uncertainty related to a cancer diagnosis, feelings of the diagnosis being dismissed as not serious, conflicting messages about adjuvant RAI treatment, and treatment-related side effects, have been raised as important concerns by thyroid cancer survivors.     

A unified approach to ion transport through membranes. I. Membrane-soluble ions.

Theoretical membrane potential transient produced by applying a current step to nerve cells has been derived based on the compartment neuron model and also on the equivalent cylinder model developed by W. Rall. It is expressed as a sum of exponential functions as

$\text{∑}\text{i=0}\text{n?1}\text{E}{}_{\mathrm{i}}\text{[1?}\text{exp}\text{(}\text{t}\text{τ}{}_{\mathrm{i}}\text{)]}$

where n is the number of compartments. The ratio of the amplitudes of the first and the second largest exponential functions, ($\text{E}{}_1\text{E}{}_0$), was found to be proportional to that of their respective time constants, ($\text{τ}{}_1\text{τ}{}_0$), in these neuron models. The constant of proportionality is given in a form that depends on the number of compartments as $\text{E}{}_1\text{E}{}_0\text{= (1 +}\text{cos}\text{π}\text{n}\text{)}\text{τ}{}_1\text{τ}{}_0$. This theoretical result is discussed in the light of recent experimental results in cat red nucleus neurons.     

哈尔滨西郊赤狐冬季巢区的初步研究

本文利用雪地跟踪方法对哈尔滨西郊5只赤狐在1985-1986年冬季的巢区做了观察。结果表明,5只狐对巢区内各部分使用的强度是不等的,对巢区中部的某些地块使用强度要高于对外围的使用,并具有明显的方向性。5个巢区的平均活动半径为320±68米至557±82米,面积为1.44-4.O9平方公里,线性指数为1.079至2。5只狐相邻距离约1000米。     

Nonglucosylated oligosaccharides are transferred to protein in MI8-5 Chinese hamster ovary cells

A CHO mutant MI8-5 was found to synthesize Man9-GlcNAc2-P-P-dolichol rather than Glc3Man9GlcNAc2-P-P-dolichol as the oligosaccharide-lipid intermediate in N-glycosylation of proteins. MI8-5 cells were incubated with labeled mevalonate, and the prenol was found to be dolichol. The mannose-labeled oligosaccharide released from oligosaccharide-lipid of MI8-5 cells was analyzed by HPLC and alpha-mannosidase treatment, and the data were consistent with a structure of Man9GlcNAc2. In addition, MI8-5 cells did not incorporate radioactivity into oligosaccharide- lipid during an incubation with tritiated galactose, again consistent with MI8-5 cells synthesizing an unglucosylated oligosaccharide-lipid. MI8-5 cells had parental levels of glucosylphosphoryldolichol synthase activity. However, in two different assays, MI8-5 cells lacked dolichol- P-Glc:Man9GlcNAc2-P-P-dolichol glucosyltransferase activity. MI8-5 cells were found to synthesize glucosylated oligosaccharide after they were transfected with Saccharomyces cerevisiae ALG 6, the gene for dolichol-P-Glc:Man9GlcNAc2-P-P-dolichol glucosyltransferase. MI8-5 cells were found to incorporate mannose into protein 2-fold slower than parental cells and to approximately a 2-fold lesser extent.